EVGN

About EVOGENE LTD. (EVGN) Stock

EVOGENE LTD. (EVGN) closed the 2026-09-17 session at $0.49, down 1.94% versus the previous close (-0.01). The stock opened at $0.50 and traded between $0.49 and $0.50 during that session. Session trading volume was 29K shares. The volume-weighted average price (VWAP) is $0.50.

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

EVOGENE LTD. has a market capitalization of $7.8 million. EVGN is listed on the XNAS exchange. The company employs approximately 52 people. The recorded listing date is 2008-03-05.

On this page you can find market EVGN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.